IP Library Granted Patent US 12,006,424
Granted Patent B2
US 12,006,424 · App. 17/288,668 · Granted Jun 11, 2024

Polymer composition suitable for gamma-ray sterilization

Inventors: Jingbo Wang (Linz, AT); Markus Gahleitner (Linz, AT); Klaus Bernreitner (Linz, AT)
Assignee: BOREALIS AG
C08L23/12A61L2/081C08K5/005C08K5/0083C08K5/01C08K5/1575C08K5/526A61L2202/23C08L2201/08C08L2203/02C08L2314/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,006,424
App. No.
17/288,668
Granted
Jun 11, 2024
Kind
B2
Abstract

The present invention is directed to a polymer composition (C) comprising a first propylene homopolymer (H-PP), at least one hydrocarbon oil, at least one nucleating agent and at least one antioxidant, a moulded article formed from said polymer composition, a process for gamma-ray sterilization of said moulded article and uses of hydrocarbon oil in said polymer composition for improving resistance to gamma-ray radiation and reducing discoloration after gamma-ray sterilization in said polymer composition.

Claims (23)

1. A polymer composition (C), comprising, based on the total weight of the polymer composition (C):

(a) 91.0 to 98.0 wt.-% of a propylene homopolymer (H-PP),

(b) 1.98 to 8.98 wt.-% of at least one hydrocarbon oil (WO),

(c) 0.01 to 0.7 wt.-% of at least one nucleating agent (NA), and

(d) 0.01 to 2.0 wt.-% of at least one antioxidant (AO);

wherein the sum of components (a), (b), (c) and (d) adds up to at least 95 wt.-% of the total weight of the polymer composition (C) and the propylene homopolymer (H-PP) is an isotactic propylene homopolymer defined by

(i) a melt flow rate MFR2 determined according to IS01133 at 230 ° C. and 2.16 kg in the range from 4.0 to 22.0 g/10 min;

(ii) a melting temperature in the range of 145 to 162° C. as determined by differential scanning calorimetry (DSC); and

(iii) a content of 2,1 erythro regio-defects in the range from 0.1 to 1.3 mol % as determined by 13C-NMR spectroscopy.

2. The polymer composition (C) according to claim 1 , having a melt flow rate MFR2 determined according to IS01133 at 230° C. and 2.16 kg in the range from 5.0 to 25.0 g/10 min.

3. The polymer composition (C) according to claim 1 , wherein the propylene homopolymer (H-PP) has a polydispersity (Mw/Mn) in the range from 2.0 to 4.5 as determined by GPC according to ISO 16014.

4. The polymer composition (C) according to claim 1 , wherein the propylene homopolymer (H-PP) is prepared in the presence of a metallocene catalyst.

5. The polymer composition (C) according to claim 1 , wherein the propylene homopolymer (H-PP) is characterized by a high isotacticity, defined as pentad regularity <mmmm> of more than 96.0 mol % as determined by 13C-NMR spectroscopy.

6. A moulded article comprising at least 90 wt. % of the polymer composition (C) as defined in claim 1 , based on the total weight of the moulded article.

7. The moulded article according to claim 6 being a medical, pharmaceutical or diagnostic article.

8. The moulded article according to claim 6 , which has been gamma-ray sterilized at a dose of at least 15 kGy.

9. The moulded article according to claim 6 , having an overall migration in the polymer composition (C) as determined according to EN ISO 1186-14:2002 on injection moulded plaques, 60×60×1 mm 3 of less than 60.0 mg/dm 2 .

10. The moulded article according to claim 6 , having a discoloration of the polymer composition (C) after gamma-ray sterilization at 50 kGy and 60 days of aging as defined by yellowness index of not higher than 23 as determined on injection moulded plaques 60×60×1 mm 3 according to standard method ASTM E313.

11. The moulded article according to claim 6 , having a Charpy notched impact strength in the range of 2.5 to 15.0 kJ/m 2 , as determined according to ISO 179 1 eA, and a retention of said impact strength after gamma-ray sterilization at 50kGy and 60 days of aging of more than 75%.

12. A process for gamma-ray sterilization of articles comprising the steps of:

providing the moulded article as defined by claim 6 , and

subjecting said moulded article to gamma-ray sterilization.

13. The process according to claim 12 , wherein the gamma-ray sterilization is carried out at a dose in the range of 15 to 150 kGy.

Assignments (2)
CHANGE OF ADDRESS Recorded Feb 23, 2022
From: BOREALIS AG
To: BOREALIS AG
Reel/Frame 059219/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: WANG, JINGBO; GAHLEITNER, MARKUS; BERNREITNER, KLAUS
To: BOREALIS AG
Reel/Frame 056038/0397 →